Patent details

EP3071219 Title: METHODS OF TREATING ANTIBODY-MEDIATED REJECTION IN ORGAN TRANSPLANT PATIENTS WITH C1-ESTERASE INHIBITOR

  • Data
  • Documents

Basic Information

Publication number:
EP3071219
PCT Application Number:
US2014066784
Type:
European Patent Granted for LU
Legal Status:
Revoked
Application number:
EP148095672
PCT Publication Number:
WO2015077543
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
METHODS OF TREATING ANTIBODY-MEDIATED REJECTION IN ORGAN TRANSPLANT PATIENTS WITH C1-ESTERASE INHIBITOR
French Title of Invention:
MÉTHODES DE TRAITEMENT DE REJET MÉDIÉ PAR LES ANTICORPS CHEZ DES PATIENTS TRANSPLANTÉS À L'AIDE D'UN INHIBITEUR DE C1-ESTÉRASE
German Title of Invention:
VERFAHREN ZUR BEHANDLUNG VON ANTIKÖRPER-VERMITTELTER ABSTOSSUNG BEI ORGANTRANSPLANTATPATIENTEN MIT C1-ESTERASE-INHIBITOR
SPC Number:

Dates

Filing date:
21/11/2014
Grant date:
14/11/2018
EP Publication Date:
28/09/2016
PCT Publication Date:
28/05/2015
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
14/11/2018
EP B1 Publication Date:
14/11/2018
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
21/11/2034
Renunciation date:
Revocation date:
19/11/2024
Annulment date:

Owner

From:
11/06/2021
 
 

Name:
Takeda Pharmaceutical Company Limited
Address:
1-1, Doshomachi 4-chome, Chuo-ku,, Osaka-shi, Osaka, Japan (JP)

History of Owners

From:
21/06/2021
To:
11/06/2021

Name:
Takeda Pharmaceutical Company Limited
Address:
1-1, Doshomachi 4-chome, Chuo-ku, 541-0045, Osaka-Shi, Osaka, Japan (JP)

From:
10/07/2020
To:
21/06/2021

Name:
Shire ViroPharma LLC
Address:
300 Shire Way, Lexington, MA 02421, United States (US)

From:
23/03/2020
To:
10/07/2020

Name:
Shire Viropharma LLC
Address:
300 Shire Way, US-Lexington, MA 02421, United States (US)

From:
07/11/2018
To:
23/03/2020

Name:
Shire Viropharma Incorporated
Address:
300 Shire Way, Lexington, MA 02421, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
21/11/2018
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
BROOM, Colin
Address:
United States (US)

2

Name:
UKNIS, Marc, E.
Address:
United States (US)

Priority

1

Priority Number:
201361907550 P
Priority Date:
22/11/2013
Priority Country:
United States (US)

2

Priority Number:
201462029086 P
Priority Date:
25/07/2014
Priority Country:
United States (US)

Classification

IPC classification:
A61K 38/55; A61K 39/395; A61P 37/00; A61K 35/16;

Publication

Bulletin

1

Bulletin Heading:
CO
Bulletin edition number:
2020/05
Publication date:
09/04/2020
Description:
Section M : Transfers of property (Art. 53 of the law), change of name and/or address

2

Bulletin Heading:
CO
Bulletin edition number:
2021/08
Publication date:
01/07/2021
Description:
Section M : Transfers of property (Art. 53 of the law), change of name and/or address

3

Bulletin Heading:
VRV
Bulletin edition number:
2025/04
Publication date:
04/03/2025
Description:
Section L: Applications for patents or supplementary protection certificates which have been withdrawn or are deemed to have been withdrawn (art. 32, 35.1, 39.5 of the law) Renunciation to a patent or supplementary protection certificate (Art. 72 of the law) Rejected applications for extensions for pediatric use of supplementary protections certificates

European Patent Bulletin

1

Issue number:
201846
Publication date:
14/11/2018
Description:
Grant (B1)

2

Issue number:
202507
Publication date:
12/02/2025
Description:
Revocation of the European patent

3

Issue number:
201851
Publication date:
19/12/2018
Description:
Application number/publication number of the divisional application (Art. 76) changed

4

Issue number:
202128
Publication date:
14/07/2021
Description:
Transfer of Rights

5

Issue number:
202033
Publication date:
12/08/2020
Description:
Transfer of Rights

Deed

Change of owner(s)

Change Kind/ Decision Type:
Change of owner(s) name/address
Deed Number:
RC20200000089A
Date Registered:
23/03/2020
Licence Effective Date:
Licence Expiration Date:
Scope of Licence:
Deed Filer:
OFFICE FREYLINGER S.A.
Journal Edition Number:
Text:
Changement de nom
Country Code:
Updated Licence Number:
Terminated Licence Number:

Added Owner(s)

Name:
Shire Viropharma LLC
Address:
300 Shire Way, US-Lexington, MA 02421, United States (US)
Name:
Address:

Change of owner(s)

Change Kind/ Decision Type:
Change of ownership
Deed Number:
RC20210000253A
Date Registered:
21/06/2021
Licence Effective Date:
Licence Expiration Date:
Scope of Licence:
Deed Filer:
Baker & McKenzie
Journal Edition Number:
Text:
Country Code:
Updated Licence Number:
Terminated Licence Number:

Added Owner(s)

Name:
TAKEDA PHARMACEUTICAL COMPANY LIMITED
Address:
1-1, Doshomachi 4-chome, Chuo-ku, 541-0045, Osaka-Shi, Osaka, Japan (JP)
Name:
Address:

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
22/10/2024
Last Annual Fee Paid Number:
11
Last Annual Fee Paid Amount:
148 Euro
Payer:
ANAQUA SERVICES (ANC. SGA2)